🚨 Moderna Shuts Down mRNA RSV Vaccine Trial in Babies After Shots Linked to Severe Side Effects, FDA Document Reveals

The U.S. FDA disclosed this week in a briefing document that rather than protecting babies as anticipated, the vaccine likely caused higher rates of severe RSV illness among the vaccinated babies enrolled in the Phase 1 clinical trials.

Commenting on the briefing document, Dr. Meryl Nass, an internist, told The Defender:

“FDA is trying to cover itself, to avoid claims of negligence. It should have anticipated VAERD, because it happened before in RSV trials — and killed babies — and because it is happening now with the COVID vaccines, which, after roughly 6 months, depending on age and dose, make the recipient more likely to get COVID.”

READ MORE ⬇️

https://childrenshealthdefense.org/defender/moderna-stops-mrna-rsv-vaccine-trial-babies-side-effects-fda/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20241211

The FDA’s vaccine advisory committee will meet tomorrow to discuss concerns about the vaccine, which the agency fast-tracked in 2021. Meanwhile, trials for investigational RSV vaccines for babies and some children are now on hold.

childrenshealthdefense.org